Conditional FDA Clearance for Certain MRIs On MAGEC Patients

The U.S. Food and Drug Administration (FDA) granted market clearance for GE Healthcare’s MAGiC (MAGnetic resonance image Compilation) software, the industry’s first multi-contrast magnetic resonance imaging (MRI) technique that delivers eight contrasts in a single acquisition in fraction of the time of conventional imaging. MAGiC is the result of a collaboration with SyntheticMR AB and gives clinicians more data than conventional scanning.

Conditional FDA Clearance for Certain MRIs On MAGEC Patients

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.